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GENETIC DISORDERS – DEVELOPMENT
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Conclusion. l-arginine rescues decreased erythropoietinL-arginine rescues decreased erythropoietin gene expression
gene expression by stimulating GATA-2 with NG-monomethyl-by stimulating GATA-2 with L-NMMA.
l-arginine.Background. NG-monomethyl-l-arginine (L-NMMA) de-
creases the expression of nitric oxide (NO) and cyclic guanosine
monophosphate (cGMP) and increases the expression of
GATA-2 mRNA and levels of GATA-2 binding activity,
Peritubular capillary interstitial cells are thought tothereby inhibiting erythropoietin (Epo) promoter activity and
be the major site of the production of erythropoietincausing a decrease in the expression of Epo protein. In the
present study, we examined the effect of l-arginine on Epo (Epo) in the kidney [1]. The cause of the anemia of renal
gene expression in Hep3B cells and BDF1 mice. disease is believed to be damage to this site of Epo pro-
Methods. Hep3B cells were incubated with and without dif-
duction [2]. In this regard, however, it is interesting toferent concentrations of L-NMMA and/or l-arginine. Anemic
note that there are some patients with the anemia ofmice were injected with phosphate-buffered saline (PBS) or
L-NAME and l-arginine. renal disease who still have the ability to produce Epo
Results. Incubation with L-NMMA under hypoxic condi- in response to acute blood loss and hypoxia [3]. On the
tions inhibited Epo expression, but this inhibition was recov- other hand, there are patients with renal failure who doered by the addition of l-arginine. Hypoxia induced the secre-
not have anemia [4]. These results suggest that chronictions of NO and cGMP, but the addition of L-NMMA inhibited
perturbation of oxygen sensing and/or signal transduc-these inductions, though these inhibitions of NO and cGMP
by L-NMMA were recovered by the addition of l-arginine. tion rather than damage at the site of Epo production
Hep3B cells transfected with the Epo promoter/enhancer-luci- [5] underlie the pathogenesis of the anemia. Recently,
ferase gene had Epo promoter activity. This activity was inhib-
it has been reported that NG-monomethyl-l-arginineited by L-NMMA, but it could be recovered by the addition of
(L-NMMA) was undetectable in non-uremic subjects,l-arginine. L-NMMA induced the binding activity of GATA-2
under hypoxic conditions. This binding activity was inhibited but markedly elevated in uremic subjects [6]. Based on
by the addition of l-arginine. The addition of cGMP inhibited this observation, we hypothesized that L-NMMA is a
L-NMMA-induced GATA-2 binding activity in a dose-depen- candidate uremic toxin responsible for the anemia ofdent manner. The results of an in vivo mouse assay revealed
renal disease [5]. However, the function of L-NMMA inthat L-NAME inhibited the expression of Epo, but this inhibi-
tion of Epo expression by L-NAME was rescued by pretreat- mediating Epo gene expression has not been elucidated.
ment with l-arginine. Since L-NMMA functions as an inhibitor of nitric oxide
synthase (NOS) [7], it was expected that it would sup-
press the production of nitric oxide (NO) and cyclic gua-
nosine monophosphate (cGMP). GATA transcription
factors have been demonstrated to bind to the GATA
element in the Epo promoter and negatively regulate
Epo gene expression [8]. Our previous study found thatKey words: L-NAME, L-NMMA, anemia, hypoxia, signal transduc-
tion, oxygen sensing, uremic toxin. L-NMMA decreased the expression of NO and cGMP
and increased the expression of GATA-2 mRNA and
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Fig. 1. Effect of L-NMMA and L-arginine on
erythropoietin (Epo) protein from Hep3B
cells stimulated by hypoxia. Hep3B cells were
incubated with 103 mol/L L-NMMA and dif-
ferent concentrations of l-arginine under hy-
poxic conditions (1% O2) for 24 hours. Epo
protein was measured by RIA. Four separate
experiments were performed (N  4). Error
bars represent one standard deviation. Sig-
nificance values are: *P 0.01 compared with
control, and **P  0.01 compared with 103
mol/L L-NMMA,.
we examined the effect of l-arginine on Epo gene expres- ase (Luc) gene in pXP2 [12], resulting in Pwt [13] or
sion in Hep3B cells and BDF1 mice to confirm our previ- V2-Ewt-Pwt-pXP2 [13]. This enhancer contained a hy-
ous hypothesis. poxia-inducible factor 1 (HIF-1) binding site and steroid
receptor response element (SRRE).
METHODS Transfection
Cell culture and RNA preparation A total of 6 to 7 105 cells in six-well (10 cm2 per well)
The Hep3B cell line was obtained from the American tissue culture plates (Falcon) were washed with serum-
Type Tissue Culture Collection (Rockville, MD, USA). free media. A mixture containing lipofectin (20 g/ well;
The cells were cultured in Dulbecco’s modified Eagle’s Life Technologies, Inc.), DNA constructs (2 g/well)
medium (DMEM; Life Technologies Inc., Gaithersburg, and -galactosidase (1 g/well) as an internal standard
MD, USA), supplemented with penicillin (100 U/mL), were co-transfected and the plates were incubated for
streptomycin (100 g/mL) and 10% heat-inactivated fe- 12 hours. The media was then changed to DMEM/FCS
tal bovine serum (FBS; Hyclone, Logan, UT, USA), in with or without L-NMMA or l-arginine and incubated
10 cm dishes. Cells were maintained in a humidified 5% for 24 hours under hypoxic/normoxic conditions.
CO2/95% air incubator at 37C. The cells were grown
under conditions of hypoxia (1% oxygen) or normoxia DNA binding assay
as previously described [9]. These cells were stimulated
Nuclear extracts were prepared as previously describedwhere appropriate by the addition of L-NMMA to the
[14]. Protein concentrations were determined by a Bio-culture medium. After incubation under hypoxic/nor-
Rad assay (Bio-Rad, Hertz, UK) using bovine serum al-moxic and/or L-NMMA-stimulated/unstimulated condi-
bumin as a standard. Sense-strand oligonucleotide (wildtions, the cells were harvested and cellular extracts were
type: CATGCAGATAACAGCCCCGAC) was end-prepared. Total cellular RNA was also prepared by con-
labeled with T4 polynucleotide kinase (Toyobo, Tokyo,ventional methods [10].
Japan) and annealed to a fourfold excess of the unla-
Plasmid vectors beled antisense oligonucleotide. Two nanograms of la-
beled probe were used in each binding reaction. TheWe used the reporter plasmid pEPLuc described by
binding buffer consisted of 10 mmol/L Tris HCl (pH 7.5),Blanchard et al [11] as a basic plasmid construct, in which
1 mmol/L ethylenediaminetetraacetic acid (EDTA), 4%both the 126-bp 3 Epo enhancer [120 to 245-bp 3 of
Ficoll, 1 mmol/L dithiothreitol and 75 mmol/L KCl. Anthe poly(A) addition site] and the 144-bp minimal Epo
equimolar mixture of poly[d(I-C)] and poly[d(A-T)] (25promoter (from118 to	26 relative to the transcription
initiation site) were placed upstream of the firefly lucifer- ng; Sigma, St. Louis, MO, USA) was used as a nonspecific
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Fig. 2. Effect of L-NMMA and L-arginine on
nitric oxide (NO) from Hep3B cells. Hep3B
cells were incubated under normoxic (21%
O2) or hypoxic (1% O2) conditions for 4 hours
in the presence or absence of 103 mol/L
L-NMMA and different concentrations of
l-arginine. NO was measured by the 2,3-dia-
minonaphthalene method. Three separate ex-
periments were performed (N  3). Error
bars represent one standard deviation. Sig-
nificance values are: *P  0.005 compared
with 103 mol/L L-NMMA, and **P0.01
compared with 103 mol/L L-NMMA. Sym-
bols are: () normoxia, 21% O2, () hypoxia,
1% O2, N  3.
Fig. 3. Effect of L-NMMA and L-arginine on cGMP from Hep3B cells
stimulated by hypoxia. Hep3B cells were incubated with 103 mol/L
L-NMMA and 103 mol/L l-arginine under hypoxic (1% O2) conditions
for 2 hours. cGMP was measured by EIA. Three separate experiments
were performed (N  3). Error bars represent one standard deviation.
Significance is *P 0.01 compared with 103 mol/L L-NMMA. Symbols
are: () normoxia, 21% O2; ( ) hypoxia, 1% O2.
competitor. The reaction mixtures (25 L) were incu-
bated for 15 minutes at 4C and then electrophoresed
on 5% nondenaturing polyacrylamide gels in 0.25TBE
buffer (22 mmol/L Tris borate, 22 mmol/L boric acid,
0.5 mmol/L EDTA) at room temperature at 150 V for
1.5 hours as previously described [14]. Gels were vac-
uum-dried and then autoradiography was performed us-
ing intensifying screens at 80C for 24 hours.
Northern blot analysis
Probes were labeled with [
-32P]deoxycytidine triphos-
phate by random priming and used in RNA blot hybrid- Fig. 4. Effect of L-NMMA and L-arginine on the induction of the Epo
ization [15]. Formaldehyde gels for RNA electrophoresis reporter constructs in Hep3B cells. Hypoxic induction of Luc gene
expression is represented as a hypoxia/normoxia ratio. Fold inductionwere prepared as described [15]. RNA blot hybridization
indicates this hypoxia/normoxia ratio. Three separate experiments (du-was performed using 25 g of total RNA from Hep3B plicate samples) were performed (N  3). Error bars represent one
standard deviation. Significance compared with control, *P  0.01.cells. The filter was hybridized to a probe of hGATA-2
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cDNA. The same filter was stripped and rehybridized
to a probe consisting of the ribosomal RNA to determine
the level of RNA in each lane. Autoradiography was
performed at 80C.
Anemic mice
BDF1 mice were injected intra-peritoneally with 0.2 mL
of 10 mg NG-nitro-l-arginine methyl ester (L-NAME)
/mL phosphate-buffered saline (PBS) or 0.2 mL of PBS as
previously described [5], and 0.2 mL of 10 mg l-arginine
added subsequently after the addition of L-NAME.
Blood samples (0.3 mL) were obtained from the orbital
vein at 0 and 24 hours after the injection of L-NAME.
Epo levels in the serum were determined by radioimmu-
noassay (RIA). Hematocrits at the times 0 and 24 hours
were 48% and 30%, respectively.
Other assays
Transfected Hep3B cells were washed with PBS and
lysed in 10 cm2 dishes with 400 L of cell lysis buffer (Pica-
Gene, Toyo Inc., Tokyo, Japan). Luc activity in 20 L
of the cell extract was determined by an Autolumat lumi-
nometer (Berthorude, Tokyo, Japan) for 10 seconds. Each
measurement of relative light units was corrected by
subtraction of the background and standardized to the
-galactosidase internal transfection control activity.
Hypoxic inducibility was defined as the ratio of the cor-
rected relative light units of the hypoxic (1% O2) dish to
those of the normoxic (21% O2) dish. NO was detected
by the 2,3 diaminonaphthalene method [16]. Intercellular
cGMP was measured by enzyme immunoassay (EIA) [17].
RESULTS
Inhibition of Epo protein by L-NMMA was recovered
by L-arginine
The effect of l-arginine was examined on the produc-
tion of Epo protein, which was inhibited by L-NMMA
in Hep3B cells. Incubation for 24 hours with 103 mol/L
L-NMMA under hypoxic conditions resulted in 70% in-
hibition of Epo, but this inhibition was recovered by
the addition of l-arginine (Fig. 1). While these results
Hep3B cells incubated with 104 mol/L L-NMMA (lanes 4 and 8), 104
mol/L L-NMMA and 104 mol/L l-arginine (lanes 5 and 9) for one
hour. The dot at the left indicates the position of the GATA-2 transcrip-
tion factor. A total of 25 ng (0.5 L is a 12.5-fold molar excess) of
competitor DNA was added to each reaction mixture (lanes 6–9). The
autoradiograph is representative of three different experiments with
similar results. (B) Densitometric analysis of the band indicated by the
circle in panel A. Intensities are expressed relative to the control.
Y-axis represents the intensity relative to that of the control. Three
experiments from using different nuclear extracts were performed (N
Fig. 5. Effect of L-NMMA and L-arginine on the expression of GATA-2. 3). Error bars represent one standard deviation. Significances are: *P
(A) EMSA was performed using 1.5 g of protein from Hep3B cells 0.005 compared with normoxia; **P  0.005 compared with hypoxia;
under normoxia (lanes 2 and 6) and hypoxia (lanes 3–5 and 7–9), from ***P  0.025 compared with 104 mol/L L-NMMA.
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Fig. 6. Effect of cGMP on the expression of GATA. (A) EMSA was performed using 1.5 g of protein from Hep3B cells incubated under hypoxia
(1% O2; lanes 2-7), with 104 mol/L cGMP (lane 3), 103 mol/L cGMP (lane 4), 104 mol/L 	 L-NMMA (lane 5), 104 mol/L 	 L-NMMA and
104 mol/L cGMP (lane 6), 104 mol/L L-NMMA and 103 mol/L cGMP (lane 7) for one hour. The autoradiograph is representative of three
different experiments with similar results. (B) Densitometric analysis of the band indicated by the circle in panel A. Intensities are expressed
relative to the control. Y-axis represents the intensity relative to that of the control. Three experiments from using different nuclear extracts were
performed (N  3). Error bars represent one standard deviation. Significance values are *P  0.01 compared with control, **P  0.025 compared
with L-NMMA 104 mol/L; ***P  0.005 compared with L-NMMA 104 mol/L.
suggest that L-NMMA specifically inhibited the produc- in NO from cells incubated with L-NMMA was expected.
tion of Epo protein in Hep3B cells, this inhibition of To this end, Hep3B cells were incubated with different
Epo by L-NMMA was recovered by l-arginine. concentrations of L-NMMA. Hypoxia induced the secre-
tion of NO, but the addition of L-NMMA inhibited this
Inhibition of NO and cGMP by L-NMMA was induction. However, inhibition of NO by L-NMMA was
recovered by L-arginine reversed by the addition of 104 mol/L l-arginine (Fig. 2).
Since NO stimulates guanylate cyclase (GC) to produceNG-monomethyl-l-arginine is known to be a nitric ox-
ide synthase (NOS) inhibitor, and therefore a decrease cGMP, a decrease in cGMP from cells incubated with
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(mean 1 SD, N  3; Fig. 4). The addition of L-NMMA
inhibited the hypoxic induction of the Luc reporter gene
expression from Pwt with a hypoxia/normoxia ratio of
only 52.5  2.7-fold, 43.9% of that from Pwt incubated
without L-NMMA (Fig. 4). These results indicate that
the hypoxic induction of the Epo gene expression is
suppressed by L-NMMA through the Epo gene regula-
tory regions. However, this inhibition of Epo promoter
activity by L-NMMA was reversed by the addition of
l-arginine, with a hypoxia/normoxia ratio of 104.2 11.1
in the presence of l-arginine and L-NMMA (Fig. 4).
Enhancement of GATA-2 binding activity by
L-NMMA was inhibited by L-arginine
To examine whether l-arginine treatment affects the
binding activity of hGATA-2, nuclear extracts were pre-
pared from cells stimulated with L-NMMA for one hour
under hypoxic conditions and an electrophoretic mobil-
ity shift assay (EMSA) was performed with an oligo-
nucleotide containing the wild-type GATA element
(AGATAA; Fig. 5). While normoxia induced the bind-
ing activity of GATA-2 (Fig. 5, lane 2), hypoxia reduced
the GATA-2 binding activity (Fig. 5, lane 3). L-NMMA
at 104 mol/L induced the binding activity of GATA-2
under hypoxic conditions (Fig. 5, lane 4), This enhanced
binding activity by 104 mol/L L-NMMA was inhibited
by the addition of 104 mol/L l-arginine (Fig. 5, lane 5).
cGMP inhibits GATA-2 binding activity
Fig. 7. Effect of L-NAME and L-arginine on serum Epo from anemic
To clarify the effect of cGMP on GATA-2 bindingmice. BDF1 mice (N  5) were injected intraperitoneally with 0.2 mL
of 10 mg NG-nitro-l-arginine methyl ester (L-NAME)/mL phosphate- activity, nuclear extracts were prepared from hypoxic
buffered saline (PBS) or 0.2 mL of PBS as previously described, and Hep3B cells incubated in the absence or presence of 1040.2 mL of 10 mg l-arginine after addition of L-NAME. Blood samples
mol/L L-NMMA and/or cGMP, and EMSA was per-(0.3 mL) were obtained from the orbital vein at 0 and 12 hours after
injection of L-NAME. Epo levels in the serum were determined by formed under the same conditions as described in Figure
RIA. Significance values are: *P  0.01 compared with PBS; **P  5. L-NMMA at 104 mol/L induced GATA-2 binding0.05 compared with PBS; ***P  0.005 compared with L-NAME.
activity (Fig. 6, lane 5), but the addition of cGMP inhib-
ited hypoxia-induced or L-NMMA-induced GATA-2
binding activity in a dose-dependent manner (Fig. 6,
lanes 2–4, 5–7).L-NMMA was also expected. To this end, hypoxic Hep3B
cells were incubated with different concentrations of
Inhibition of serum Epo by L-NAME in vivo wasL-NMMA. As shown in Figure 3, hypoxia induced the
recovered by L-argininesecretion of cGMP, but the addition of 103 mol/L
L-NMMA inhibited this induction. This inhibition of L-NAME was examined using an in vivo mouse assay,
since L-NMMA has been reported to be catabolized bycGMP by L-NMMA was reversed by the addition of
103 mol/L l-arginine. NG-dimethylarginine dimethylaminohydrolase (DDHA)
in the intact kidney [18, 19]. However, L-NAME is not
Inhibition of Epo promoter activity by L-NMMA was catabolized by this enzyme [20]. Hecker et al observed
recovered by L-arginine that L-NMMA was rapidly hydrolyzed to l-citrulline
and lost its inhibitory effect in endothelial cells [21].Pwt was transfected into Hep3B cells, and the cells in-
cubated in the presence or absence of L-NMMA and/or Furthermore, L-NMMA is continuously released into
body fluids during the in vivo breakdown of proteinsl-arginine under 21% (normoxia) or 1% (hypoxia) oxy-
gen for 24 hours. The hypoxic induction of Luc gene and was assumed to be readily excreted in urine without
re-incorporation into proteins or further degradation inexpression is represented as a hypoxia/normoxia ratio,
as previously described [8]. Hypoxic expression from Pwt intact animals [18]. To identify the effect of L-NAME
on Epo production in vivo, BDF1 mice were injectedwas 119.5 6.7-fold higher than that from normoxic Pwt
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intra-peritoneally with 0.2 mL of 5 mg L-NAME/mL
PBS and/or 0.2 mL of 10 mg l-arginine or 0.2 mL of
PBS as a control as previously described [5]. Blood sam-
ples (0.3 mL) were obtained from the orbital vein imme-
diately after (0 hour) and at 12 hours after the injection
of L-NAME (Fig. 7). Twelve hours after the injection,
the serum Epo was 50.6 mU/mL in the control and
28.5 mU/mL in the L-NAME-injected mice. However,
it was 65.1 mU/mL in the l-arginine-injected mice. The
serum Epo from the pretreatment of l-arginine and sub-
sequent L-NAME-injected mice was 56.0 mU/mL (Fig. 7).
These results indicated that l-arginine rescued the de-
crease of Epo by L-NAME.
Enhancement of GATA-2 mRNA expression by
L-NMMA was inhibited by L-arginine
To examine whether the level of GATA-2 expression
was affected by the addition of L-NMMA, a Northern
blot analysis was performed. The Northern blot analysis
showed that hypoxia reduced GATA-2 mRNA expres-
sion (Fig. 8A, lane 2), while L-NMMA induced the ex-
pression of GATA-2 mRNA (Fig. 8A, lane 3). However,
the addition of l-arginine inhibited this enhancement of
GATA-2 mRNA by L-NMMA (Fig. 8A, lane 4). The
28S used as a control revealed a constant level of mRNA
expression from the cells incubated under normoxia or
hypoxia and with or without L-NMMA (Fig. 8A).
DISCUSSION
Nitric oxide-cGMP-G kinase is one of the pathways
of hypoxia-induced signal transduction of Epo gene ex-
pression [22]. In chronic renal failure, we suspect that
an inhibitor such as L-NMMA suppresses Epo gene ex-
pression through inhibition of NO production [5]. Our
previous study found that L-NMMA decreased the ex-
pression of NO and cGMP and increased the expression
of GATA-2 mRNA and the level of GATA-2 binding
activity, thereby inhibiting Epo promoter activity and
causing a decrease in the expression of Epo protein [5].
The effects of L-NMMA on HIF-1, hepatic nuclear
factor 4 (HNF-4), chicken ovalbumin upstream promotor
transcription factor 1 (COUP-TF1), nuclear factor-B
(NF-B) were assessed by EMSA and an Epo promoter
and hypoxia with 103 mol/L L-NMMA and 103 mol/L l-arginine (lane
4) for eight hours. Upper and lower panels show GATA-2 and 28S
mRNA, respectively. The autoradiograph is representative of three
different experiments with similar results. (B) Densitometric analysis
of the band of GATA-2 in panel A. Intensities are expressed relative
to the control. Three experiments from using different nuclear extracts
Fig. 8. Effect of L-NMMA on the expression of GATA-2 mRNA. (A) were performed (N  3). Error bars represent one standard deviation.
Northern blot analysis was performed using 25 g of RNA from Hep3B Significance values are: *P  0.005 compared with normoxia; **P 
cells incubated under normoxic conditions (21% O2; lane 1), hypoxic 0.005 compared with hypoxia; ***P  0.005 compared with hypoxia 	
conditions (1% O2; lane 2), hypoxia with 103 mol/L L-NMMA (lane 3) 103 mol/L L-NMMA.
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assay. L-NMMA did not alter the binding activity of renal disease is necessary to clarify the details of the
HIF-1, HNF-4, COUP-TF1, or NF-B at all. Neither pathogenesis of the anemia of renal disease.
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